Table 7 The clinical characteristics of patients in the two risk groups in TCGA-UM cohort (n = 80)
| Clinical characteristics | Low-risk group (n = 31) | High-risk group (n = 49) |
|---|---|---|
| Gender | ||
| Male | 18 (51.4) | 27 (55.1) |
| Female | 13 (48.6) | 22 (44.9) |
| T staging | ||
| T2 | 8 (25.8) | 6 (12.3) |
| T3 | 14 (45.2) | 18 (36.7) |
| T4 | 9 (29.0) | 25 (51.0) |
| M staging | ||
| M0 | 21 (67.7) | 30 (61.2) |
| M1 | - | 4 (8.2) |
| Unknown | 10 (32.3) | 15 (30.6) |
| N staging | ||
| N0 | 21 (67.7) | 31 (63.3) |
| Unknown | 10 (32.3) | 18 (36.7) |
| TMN stages | ||
| II | 20 (64.5) | 19 (38.8) |
| III | 11 (35.5) | 25 (51.0) |
| IV | - | 4 (8.2) |
| Unknown | - | 1 (2.0) |